Metastatic Adenocarcinomas of the Stomach or Esophagogastric Junction (UICC Stage IV) Are Not Always a Palliative Situation: A Retrospective AnalysisHumansEsophagogastric JunctionAdenocarcinomaNeoadjuvant TherapyHospital MortalityPalliative CareGastrectomy
He will be a FOUR YEAR survivor of Stage 4 Pancreatic Cancer. He is also trying to get the word out about our drug that has given him almost FOUR wonderful years. He works full time, except when he is hunting or fishing or getting chemo. ...
Pancreatic ductal adenocarcinoma (PDAC), one of the deadliest cancers and a leading cause of all cancer-related deaths in the United States, typically goes undetected until it spreads and becomes unresectable and metastatic2. In contrast, for the few patients (~15%) diagnosed with localized ...
Levine AW, Donegan WL, Irwin M (1982) Adenocarcinoma of the colon with hepatic metastases. Fifteen-year survival. JAMA 247:2809–2810 Article CAS PubMed Google Scholar Perez N, Tournigand C, Mabro M, Molitor JL, Artru P, Carola E, Andre T, Louvet C, Krulik M, de Gramont A (2004...
, depending on thecell of origin. about 93% of pancreatic cancers are exocrine tumors, the most common among them being pancreatic ductal adenocarcinoma(pdac), also called pancreatic adenocarcinoma. the remaining are neuroendocrine tumors (pnet), also called islettumors, which often grow more ...
Iwatsuki S, Dvorchik I, Madariaga JR, Marsh JW, Dodson F, Bonham AC, Geller DA, Gayowski TJ, Fung JJ, Starzl TE: Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 1999, 189: 291-299. 10.1016/S1072-7515(99)00089-...
(a) The histologic type of the tumor was not called adenocarcinoma, and the pathological diagnosis was uncertain or questionable. (b) The tumor was evaluated clinically unresectable by the multi-disciplinary team. (c) Patients received R2 resection. (d) Patients had a history of CRC radical ...
Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma. To evaluate the safety and efficacy of a modified administration schedule of docetaxel, cisplatin, and fluorouracil (mDCF) with bevacizumab in patients wit... MA...
depending on each metastatic condition in stage IV GC. The main metastatic pathways of GC can be divided into three categories: lymphatic, hematogenous, and peritoneal. In each category, considerable historical data on conversion surgery have demonstrated the benefits of individualized approaches. However...
Stoehlmacher J, Derigs HG, Hegewisch-Becker S, Grossmann J, Pauligk C, Atmaca A, Bokemeyer C, Knuth A, Jager E (2008b) Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistis...